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ABSTRACT  We isolated the cDNA of a steroid receptor-binding protein, SRB-RGS, binding 
to the estrogen receptor (ER)α. SRB-RGS very efficiently suppressed the ERs-mediated 
transcriptional activities. SRB-RGS interacted with ER on DNA. SRB-RGS was localized in 
both the nucleus and cytoplasm in the cells. SRB-RGS induced cell death of HeLa cells. In the 
present paper, we examined the functional domains of SRB-RGS. The effects of SRB-RGS on 
the ERs-mediated transcriptional activities were exerted by the PDZ domain-containing region 
and/or the RGS domain-containing region of SRB-RGS. The nuclear localization signal (NLS) 
was in the RGS domain containing one basic region. Either the PDZ or RGS domains on SRB-
RGS induced cell death. Either the PDZ or RGS domains on SRB-RGS were necessary for 
transcriptional suppression, subcellular localization and induction of the death in HeLa cells. 
The expression of SRB-RGS was observed in the cytoplasm or both the cytoplasm and nucleus 
of various types of cells by confocal laser-scanning microscopy after immunostaining of the 
cells. SRB-RGS was expressed in all types of cells examined by using real-time RT-PCR.
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INTRODUCTION
   The biological actions of estrogens are mediated 
through binding to two specific estrogen receptors 
(ERs), ERα or ERβ, which belong to the nuclear 
receptor superfamily, a family of ligand-regulated 
transcriptional factors. Steroid hormone receptors 
have been indicated to be composed of six major 
functional domains, i.e., the A/B domains in the 
NH2-terminal region of the protein as the activation 
function 1 (AF-1), domain C as the DNA-binding 
domain arranged in two zinc-stabilized DNA-
binding motifs, domain D as a hinge region which 
contains a nuclear localization signal, and domain 
E/F as the ligand-dependent transcription domain 
(activation function 2 (AF-2)). For the activation of 
transcription, the steroid hormone receptors recruit 
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bearing a PDZ domain at the NH2-terminal and 
the regulator of the G-protein signaling (RGS) 
domain at the COOH-terminal, designated as 
SRB-RGS. SRB-RGS very efficiently suppressed 
the ERs-mediated transcriptional activities. The 
interactions between SRB-RGS and ERs were 
revealed by a coimmunoprecipitation assay and a 
mammalian two-hybrid system. A gel shift assay 
revealed that SRB-RGS interacted with ER on 
the DNA. Green fluorescence of enhanced green 
fluorescence protein (EGFP)-tagged SRB-RGS was 
observed in both the nucleus and the cytoplasm in 
the cells by confocal laser-scanning microscopy. 
Overexpression of SRB-RGS induced cell death of 
HeLa cells. Intrinsic SRB-RGS was observed by 
Western blotting and by confocal laser-scanning 
microscopy after immunostaining of the cells. 
SRB-RGS was recently registered as G-protein 
signaling 3 (RGS3) in the secondary DNA database 
(Accession No.NM019340) of the National Center 
for Biotechnology Information (N.C.B.I.) of the 
U.S. National Library of Medicine (Bethesda 
MD, U.S.A.) by others. Six kinds of human-origin 
(h)RGS3 are known (Fig.1). SRB-RGS is called 
isoform 1 of rat RGS3 on Entrez Gene of N.C.B.I. 
The other rat isomers are not known yet. SRB-RGS 
coactivators allowing the local decondensation 
of chromatin. In the next step, the DRIP/TRAP 
complex binds to the AF-2 of the receptor and 
mediates transcriptional activation. The receptors 
in the absence of ligands bind to the corepressors, 
such as N-CoR and SMRT. The corepressors recruit 
histone deacetylase (HDAC) and thereby suppress 
the transcriptional activity１－４）. 
   G-protein coupled receptors (GPCRs) on the cell 
surface mediate activation of effectors in many 
physiological responses. Agonist binding to the 
GPCR induces the direct activation of the Gα 
subunit, triggering the exchange of guanosine-5'-
diphosphate (GDP) to guanosine-5'-triphosphate 
(GTP), and Gβγ is capable of activating or 
inhibiting effectors. The intrinsic GTPase activity 
of Gα is quite slow. The regulator of the G-protein 
signaling (RGS) protein for Gα subunits enhances 
the hydrolysis of GTP bound to Gα. This GTPase-
activating protein (GAP) activity enhances G-protein 
deactivation５－９）.
   We have cloned the cDNA of the protein that 
interacted with domains C and D of the rat-
origin estrogen receptorα(rERαC/D) from a 
rat ovary cDNA library, which was the cDNA of 
a novel steroid receptor-binding (SRB) protein 
Fig. 1. A schematic representation of the SRB-RGS and human-origin (h)RGS3 isoforms. The amino acid (aa) numbers of SRB-
RGS are shown above the schema. PDZ and RGS represent the PDZ and RGS domains, respectively.
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is the first RGS3 for which the full-length cDNA has 
been registered (DDBJ/GenBank/EMBL Accession 
No.AB055153)２，３）.
   The amino acids (aa) (SRB-RGS aa839-899 and 
aa909-954) for the alpha-helical structure (α1 to α5 
and α6 to α9, respectively) of the RGS domains on 
SRB-RGS are conserved among species. SRB-
RGS asparagine-908 (N) corresponding to the 
critical asparagine-128 of RGS4 to interact with 
the Gα subunit and cause GTPase acceleration 
is also conserved. The regions aa789-792 and aa 
808-810 of SRB-RGS (two Bs in the RGS domain) 
correspond to two stretches of the positively charged 
amino acids of partial RGS3, Arg341LysArgLys 
and Arg360ArgArg, which have been reported as 
the putative nuclear localization signal (NLS) 
sequence. Overexpression of a shorter form of 
the partial hRGS3 (called hRGS3T) followed by 
serum deprivation induced apoptosis of CHO cells. 
The acidic region (SRB-RGS aa651-675) was 
presumed to be a coiled coil5，6）. The PDZ domain 
is a multi-functional protein-protein interaction 
module that plays important roles in organizing 
signal transduction complexes, clustering membrane 
proteins and maintaining cell polarity７，10，11）. 
   In this paper, the effects of SRB-RGS on 
suppression of the ERs-mediated transcriptional 
activities were exerted by the PDZ domain-
containing region and the RGS-containing region of 
SRB-RGS using deletion mutants of SRB-RGS. The 
two regions may act on the suppression of the ERα- 
and ERβ-mediated transcriptional activities. The 
nuclear localization signal (NLS) was in the RGS 
domain containing at least one basic region. Either 
the PDZ or RGS domains on SRB-RGS induced cell 
death. The expression of SRB-RGS was observed by 
confocal laser-scanning microscopy. SRB-RGS was 
found to be expressed in all the cell types examined 
by quantitative real-time RT-PCR. 
MATERIALS AND METHODS
Construction of plasmids
   The full-length SRB-RGS expression vector, 
pcDNASRB-RGS aa1-967 (Fig.2 No.10), was 
constructed by inserting SRB-RGS cDNA into the 
multi-cloning site (MCS) of pcDNA3 (Fig.2 No.1) 
(Invitrogen Co., Groningen, The Netherlands) driven 
by a cytomegalovirus (CMV) promoter as described 
previously２，３）. The expression vector of the 
deletion mutants of SRB-RGS was constructed by 
modifying pcDNASRB-RGS.　The construction of 
the expression vectors of hERα, pcDNA-hERα and 
hERβ, pcDNA-hERβ was described previously２，３）. 
   The expression vector for the EGFP-tagged 
full-length SRB-RGS aa1-967, pEGFPSRB-RGS 
aa1-967, was constructed by inserting the cDNA 
fragment of SRB-RGS PCR-amplified from the 
expression vector, pcDNASRB-RGS into the 
EcoRI site of MCS of pEGFP-C1 (Clontech Co., 
Palo Alto, CA, U.S.A.). The expression vectors of 
the EGFP-tagged deletion mutants of SRB-RGS 
were constructed by modifying pEGFPSRB-RGS 
aa1-967. 
Cells, cell culture and transfection
   COS-7 cells (an African green monkey kidney 
fibroblast cell line), HeLa cells (a human epithelial 
cervical cancer cell line), PC-12D cells (a rat 
pheochromocytoma cell line), rat-1 cells (a rat 
fibroblast-like cell line) and HUC-F2 cells (a 
normal umbilical cord fibroblast, female) were 
purchased from The Institute of Physical and 
Chemical Research (RIKEN) (Wako, Japan). 
MCF-7 cells (a human breast cancer cell line) was 
from the Health Science Research Resources Bank 
(Osaka, Japan). A431 cells (a human epidermoid 
carcinoma cell line) were a gift from Dr. Okamoto 
(Kawasaki Medical School). MDA-MB-231 cells, 
MDA-MB-157 cells, KPL-1 cells, KPL-4 cells, 
KPL-3C cells, BT-474 cells and HCC1937 cells 
(human breast cancer cell lines) are maintained 
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by Dr. Kurebayashi (one of the authors). The cells 
were routinely maintained in Dulbecco's modified 
Eagle's minimal essential medium (DMEM) 
(Sigma Co., St. Louis, MO, U.S.A.) supplemented 
with 10% fetal bovine serum (FBS) (Medical & 
Biological Laboratories Co., Nagoya, Japan) in 
5% CO2 at 37℃. The cells grown in screw-capped 
flasks (25 cm2) or on glass cover slips in 35-mm 
dishes were transiently transfected with plasmids by 
lipofectamine2000 (Invitrogen Co., CA, U.S.A.) and 
incubated for 48 h after transfection. 
Chloramphenicol acetyltransferase assay 
   The chloramphenicol acetyltransferase (CAT) 
assay, using a FAST CAT Yellow (deoxy) CAT assay 
kit (Molecular Probes, Eugene, OR, U.S.A.), and 
the β-galactosidase (β-gal) assay were performed 
as described previously３）. Briefly, the medium 
for COS-7 cells in a screw-capped flask (25 cm2) 
was replaced by phenol red-free MEM (Nissui 
Pharmaceutical Co., Tokyo, Japan) supplemented 
with 10% dextran-coated charcoal-treated (DCC) 
FBS for 48 h before transfection. The COS-7 cells 
were cotransfected with plasmids as indicated 
and incubated for 48 h in the presence of 10-7 M 
estradiol (E2) after transfection. The cell extract 
was prepared according to the manufacturer's 
manual. A portion of the cell extract was incubated 
with fluorescent deoxychloramphenicol substrate 
and acetyl CoA at 37℃ for 2 h. The acetylated 
derivative and the substrate were quantified by 
measuring the absorbance using a Model F-3010 
fluorescence spectrophotometer (Hitachi Co., 
Tokyo, Japan). For the β-gal assay, the other portion 
of the cell extract was incubated with o-nitrophenyl 
β-galactopyranoside at 37℃ for 30 min. The 
relative CAT activities were calculated according 
to the manufacturer's manual and normalized by 
β-gal activities. The CAT activity for the cells 
cotransfected with the empty plasmid, pcDNA3 
instead of pcDNA-hERα or pcDNA-hERβ was 
subtracted from each CAT activity.
Anti-SRB-RGS antibody 
   The anti-SRB-RGS peptide antiserum was 
prepared as mentioned previously２）. The anti-
SRB-RGS peptide antiserum was raised against 
a 18-amino acid peptide sequence corresponding 
to SRB-RGS residues 504-521 (QEA APG PES 
PSS EDI ATC). The peptide was conjugated to 
keyhole lympet hemocyanin (KLM) as a carrier 
with SH group of COOH-terminal cysteine and 
immunized a rabbit. The immune and preimmune 
sera were purified and called as the anti-SRB-RGS 
antibody and the preimmune immunoglobulin (IgG), 
respectively.
Immunostaining of the cells
   The cells grown on glass cover slips were fixed in 
4% paraformaldehyde for 1 h at room temperature. 
After permiabilization with 2% Triton X-100 in 
PBS for 10 min at room temperature, the cells were 
blocked with 20% FBS in PBS and incubated with 
the anti-SRB-RGS antibody or preimmune serum 
and then fluorescein-5-isothiocyanate (FITC)-
conjugated anti-rabbit immunoglobulin (IgG, 
IgA and IgM) (ICN Pharmaceuticals, Aurora OH, 
U.S.A.). They were observed on a confocal laser-
scanning microscopy as described below. 
Observation of subcellular localization and TUNEL 
assay
   The HeLa cells or COS-7 cells grown on glass 
cover slips in 35-mm dishes were transiently 
transfected with pEGFP-C1, pEGFPSRB-RGS or 
pEGFPSRB-RGS derivatives (2μg for observation 
of subcellular localization, 3μg for TUNEL assay). 
The TUNEL assay was performed as mentioned 
previously３）. Briefly, an ApoTagR Red In Situ 
Apoptosis Detection kit (Intergen Co., NY, U.S.A.) 
was used for the assessment of DNA fragmentation 
in the cells transfected with the plasmids after 
47Ikeda M, et al. : Characterization of a steroid receptor-binding protein, SRB-RGS
fixation of the cells on glass cover slips. DNA 
fragments were labeled with the digoxigenin-
nucleotide and then bound an anti-digoxigenin 
antibody conjugated to Rhodamine. The cells were 
viewed on a confocal laser-scanning microscope as 
mentioned below.
Observation of the cells by confocal laser-scanning 
microscopy 
   The cells in 35-mm dishes were grown on glass 
cover slips in DMEM supplemented with 10% 
FBS２，３）. The cells were washed with PBS and 
fixed in 4% paraformaldehyde for 1 h. The cover 
slips were mounted on glass slides after or without 
propidium iodide (PI) staining of the cells. The cells 
were viewed on a Fluoview FV300 confocal laser-
scanning microscope (Olympus Co., Tokyo, Japan). 
Real-time RT-PCR
   Total RNA was prepared from the cells by using 
an RNeasy PLUS Mini kit (Quiagen GmbH, Hilden, 
Germany) according to the manufacturer's manual. 
Briefly, the homogenized lysate was centrifuged in 
a DNA Eliminator spin column and in an RNeasy 
spin column to get total RNA. The RNA extracts 
were incubated with RNase-free DNase (Promega 
Co., Madison, WI, U.S.A.). The total RNA was 
converted to cDNA by iScript cDNA synthesis 
kit (Bio-Rad Co., Hercules, CA, U.S.A.). Control 
cDNAs were prepared by no-reverse transcriptase 
reactions in which reverse transcriptase was omitted 
from the reverse transcriptase reaction. All values 
were subtracted the values from control cDNAs. 
Power SYBR green-based real-time RT-PCR 
Master Mix (Applied Biosystems, Warrington, 
U.K.) using a 7300 Fast Real-Time PCR System 
or PRISMR 7700 Sequence Detection System 
(Applied Biosystems). The following primer pairs 
were used with PRISM 7700 Sequence Detection 
System: 5'-ATC AGG ATA TGT GGC GGA TGA-3' 
(forward) and 5'-CTG ATT TGT GTA GTC GGT 
TTA TGC A-3' (reverse) for amplification of β-gal; 
5'-CCA CCA ACC AGT GCA CCA TT-3'  (forward) 
and 5'-GGT CTT TTC GTA TCC CAC CTT TC-3' 
(reverse) for amplification of hERα; and: 5'-AGA 
GTC CCT GGT GTG AAG CAA G-3'  (forward) 
and 5'-GAC AGC GCA GAA GTG AGC ATC-3' 
(reverse) for amplification of hERβ. The plasmids 
pcDNAβ-gal, pcDNA-hERα and pcDNA-hERβ 
were used as standards for the quantification for 
β-gal, hERα and hERβ cDNAs, respectively. The 
following primer pairs were used in conjunction 
with the 7300 Fast Real-Time PCR System: 5'-ATT 
GGA GCT CGC AGC TCA GA-3' (forward) and 
5'-GCT TCT CAC AAG GCA TTG GC-3'(reverse) 
(these primers amplify a part of the STS sequenced 
directly from African green monkey genomic DNA 
with the human forward and reverse primers) for 
amplification of SRB-RGS; and 5 '-GTA ACC 
CGT TGA ACC CCA TT-3' (forward) and 5'-CCA 
TCC AAT CGG TAG TAG CG-3' (reverse) for 
amplification of human 18S ribosomal (r)RNA as an 
endogenous control12）; as well as the above primer 
pairs for amplification of hERα and hERβ. The 
values were normalized to the respective value for 
18S rRNA. The reactions were performed at 95℃ 
for 10 min followed by 40 cycles of 95 ℃ for 15 sec 
and 60℃ for 1 min. 
RESULTS
Functional domain of SRB-RGS for the transcriptional 
suppression
   SRB-RGS very efficiently suppressed the ERs-
mediated transcriptional activities２，３）. SRB-RGS 
holds two major putative functional domains, PDZ 
and RGS domains. We examined the functional 
domain(s) of SRB-RGS involved in suppression 
of the hERα- and hERβ-mediated transcriptional 
activities. As indicated at the bottoms of Fig.2 
B1 and 2 B2, the expression vectors of hER
α, pcDNA-hERα or hERβ, pcDNA-hERβ (or 
their empty plasmid, pcDNA3) and the reporter 
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plasmid for ERs-mediated transcriptional activities, 
pEREtkCAT, were also cotransfected into COS-7 
cells along with the expression vector of the SRB-
RGS derivatives (the full length or the deletion 
mutants of SRB-RGS), the pcDNASRB-RGS 
derivatives or the empty plasmid, pcDNA3 . 
The expression vector of β-gal, pcDNAβ-gal, 
was cotransfected to normalize the transfection 
efficiency. The full-length SRB-RGS (No.10) 
effectively suppressed the hERα- and hERβ
-mediated transcriptional activities (Fig.2 B1 and 2 
B2; Nos.10, respectively), as described previously3）. 
Stepwise deletion of the RGS domain-containing 
region (Nos.3-9 for hERα, Nos.5-9 for hERβ) did 
not release the activity of SRB-RGS. Deletion of 
SRB-RGS aa6-159 from SRB-RGS aa1-159 or 
Fig. 2. Functional domain of SRB-RGS for the transcriptional suppression. (A) Functional domains and derivatives of SRB-
RGS. PDZ domain: a protein/protein interaction module; RGS domain: the regulator of G-protein signaling domain. (B1 and 2) 
Effects of SRB-RGS derivatives on ERα- or ERβ-mediated transcription activities. COS-7 cells were transiently transfected with 
plasmids as indicated at the bottom of the figure. The cells were incubated for 48 h in the presence of 10-7 M estradiol. The CAT 
activity for the cells cotransfected with the empty plasmid, pcDNA3 instead of pcDNA-hERα or pcDNA-hERβ, was subtracted 
from each CAT activity. In each graph, the activity in cells transfected with pcDNA3 (No.1) was represented as 100%. The 
numbers at the top of the bars in the graphs represent the percent activity. The numbers under the x-axes represent the plasmid 
numbers shown above. Values are the means of three or more independent experiments±SD. (B3) Quantitative analysis of the 
estrogen receptors. The amount of hERα or hERβ overexpressed in COS-7 cells in the above experiments (B1 and B2) was 
quantified by real-time RT-PCR. The values were normalized by the respective β-gal value. The values are the means of three or 
more independent experiments±SD. (B4) Quantitative analysis of intrinsic SRB-RGS and overexpressed hERα  The amounts of 
intrinsic SRB-RGS and overexpressed ERα in COS-7 cells in the above experiment (B2 No.1) were quantified by real time RT-
PCR. The values were normalized by the respective value of 18S ribosomal (r)RNA value. The values are the means of three or 
more independent experiments. The values by plasmid No.1 were represented as 100%.
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SRB-RGS aa6-541 from SRB-RGS aa1-541 released 
the transcriptional suppression activities on the hERα- 
and hERβ-mediated transcriptional activities (Fig.2 
B1 and 2 B2; Nos.2, respectively). Both SRB-RGSs 
aa6-159 and aa6-541 bore the PDZ domains. The 
N-terminus-deleted RGS domain-containing region 
(with effective regions, aa6-159, aa6-541 deleted) 
(No.11) was still effective for the suppression of the 
hERα- and hERβ-mediated transcriptional activities 
(Fig.2 B1 and 2 B2; Nos.11, respectively). 
   The amounts of hERα and hERβ expressed in 
Fig.2 B1 and 2 B2, respectively, were quantified 
by real-time RT-PCR (Fig.2 B3). The amounts 
of hERα and hERβ expressed were normalized 
the transfection efficiency by the amount of 
β-gal expressed. The relative amounts among hERα 
expressed were similar each other when compared 
to the values of No.1 represented as 100 % (Fig.2 
B3  hERα/β-gal No.1-11).  Also the relative 
amounts among hERβ expressed were similar each 
other (Fig.2 B3 hERβ/β-gal No.1-11). That is, the 
differences among the CAT activities in Fig.2 B1 
and 2 B2 were not caused by the differences of the 
amount of the hERα and hERβ expressed.
   As mentioned below, the COS-7 cells express 
intrinsic SRB-RGS. We quantified the levels of 
intrinsic SRB-RGS and hERα overexpression under 
the condition in Fig.2 B1 No.1 by real-time PCR. 
The amount of intrinsic SRB-RGS was about 12% 
of the amount of hERα overexpressed (Fig.2 B4). 
In these experiments, the influence of intrinsic SRB-
RGS was likely not pronounced. And we could 
compensate for this effect by the use of the controls 
(Fig.2 B1 and 2 B2 Nos.1) 
Functional domain of SRB-RGS for subcellular 
localization 
   We previously demonstrated that the EGFP-
tagged SRB-RGS was localized in both cytoplasm 
and nucleus of COS-7 cells3）. Here, we examined 
the functional domain of SRB-RGS for subcellular 
localization. The expression vectors of the EGFP-
tagged SRB-RGS derivatives (Fig.3) were transfected 
into COS-7 cells. The EGFP itself, as well as the 
EGFP-tagged SRB-RGSs aa1-103 and aa1-543, 
were localized in both the cytoplasm and nucleus. They 
Fig. 3. A schematic representation of EGFP-tagged SRB-RGS and SRB-RGS derivatives.  The numbers are the amino acid (aa) 
numbers. On the right side of the figure, the results (subcellular localization and TUNEL assay in Figs.4 and 5) obtained using 
these plasmids are summarized. B: the positively charged amino acids;
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do not have the remarkable nuclear localization 
abilities. There are three regions of basic amino 
acids on SRB-RGS, aa708-712 ,  aa789-794 , 
aa808-810, which are indicated with the letter B in 
Figs.2 and 3. These regions were candidates for the 
nuclear localization signals. We examined whether 
these regions had nuclear localization ability. The 
EGFP-tagged SRB-RGSs aa1-812 and aa1-762 were 
localized in the cytoplasm. SRB-RGS aa813-967 
likely has the nuclear localization signal(s). We 
examined whether the COOH-terminal domain itself 
had nuclear localization ability. The EGFP-tagged 
SRB-RGSs aa699-967, aa763-967 and aa801-967 
bore three, two and one basic region(s), respectively, 
and were all localized in the nucleus. SRB-RGS 
aa813-967 (with the three basic regions deleted) 
reduced the nuclear localization ability and was 
localized in both the cytoplasm and nucleus. And 
as mentioned above, SRB-RGS aa1-812, in which 
three basic regions were cotained, was localized in 
the cytoplasm. Consequently, SRB-RGS aa813-967 
was a least region containing the nuclear localization 
ability. The nuclear localization ability of SRB-RGS 
aa813-967 was enhanced by the addition of at least 
one basic region (see SRB-RGS aa801-967). EGFP-
tagged SRB-RGS aa543-967 (with an acidic region 
contained) was localized in both the cytoplasm 
and nucleus. The acidic region-containing region 
reduced the nuclear localization ability of SRB-RGS 
aa699-967.
Functional domain of SRB-RGS for inducing cell 
death 
   Overexpression of SRB-RGS in HeLa cells induced 
cell death3）. That is, HeLa cells which the green 
fluorescence of the overexpressed EGFP-tagged 
SRB-RGS was observed were TUNEL-positive (i.e. 
that showed red fluorescence). Here, we examined the 
functional domain of SRB-RGS that was responsible 
for the induction of cell death. The expression 
vectors of EGFP itself or the EGFP-tagged SRB-
RGS derivatives shown in Fig.3 were transfected 
Fig. 4. Functional domain for subcellular localization. The COS-7 cells were transiently transfected with pEGFP-C1, pEGFPSRB-
RGS or pEGFPSRB-RGS derivatives. Fluorescence was observed by a confocal laser-scanning microscope after staining of the 
nucleus with PI. Green fluorescence: EGFP; red fluorescence: PI.
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into HeLa cells or COS-7 cells. Fluorescence was 
observed by confocal laser-scanning microscopy 
after the TUNEL assay was performed on the cells 
to assess DNA fragmentation. EGFP itself did not 
induce cell death of HeLa cells. The EGFP-tagged 
full-length SRB-RGS (green fluorescence) induced 
cell death (red fluorescence) as shown by the color 
yellow (merge) (Fig.5). Although SRB-RGS aa1-103 
induced cell death, SRB-RGS aa1-543 did not 
induce. The cell death-inducing ability of SRB-RGS 
aa1-103 may be inhibited by SRB-RGS aa104-543. 
SRB-RGSs aa1-762 and aa1-812 (with SRB-RGS 
aa1-543 plus aa544-762 contained and RGS domain 
deleted) induced cell death. The inhibition (by 
SRB-RGS aa103-543) of the cell death-inducing 
ability of SRB-RGS aa1-103 was cancelled by 
aa543-762. Next, we examined whether the RGS 
domain is necessary for cell death. The SRB-RGSs 
aa543-967, aa699-967, aa763-967 (with the whole 
RGS domain contained) and aa801-967 induced 
cell death. The SRB-RGS aa813-967 almost did not 
induce cell death. The SRB-RGS aa801-967 was 
a COOH-terminal region required for cell death. 
Taken together, either the PDZ domain (SRB-RGS 
aa1-103) or the RGS domain (SRB-RGS aa801-967) 
was the cell death-inducing domain. 
   On the other hand, the EGFP-tagged full-length 
SRB-RGS and SRB-RGSs aa1-103 and aa699-967 
as well as EGFP itself３）did not induce cell death of 
COS-7 cells (Fig.5B). 
Examination of SRB-RGS expression by confocal 
laser-scanning microscopy and by quantitative real-
time PCR 
   SRB-RGS suppressed the ERs-mediated 
transcriptional activities as described previously２，３）. 
Fig. 5. Functional domains for cell death. The HeLa cells (A) or COS-7 cells (B) grown on glass cover slips in 35-mm dishes 
were transiently transfected with pEGFP-C1, pEGFPSRB-RGS or pEGFPSRB-RGS derivatives (3μg each). Fluorescence 
was observed by a confocal laser-scanning microscope after the TUNEL assay was performed on the cells to assess DNA 
fragmentation, as described in the MATERIALS AND METHODS. Red fluorescence: staining by TUNEL assay; green 
fluorescence: EGFP.
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A reduced amount and/or functional defect of SRB-
RGS may affect the cell growth via release of the 
suppression. We examined the SRB-RGS expression 
in the cells by confocal laser-scanning microscopy 
and by quantitative real-time RT-PCR. 
   The expression of SRB-RGS was observed 
by confocal laser-scanning microscopy after 
immunostaining of the cells. SRB-RGS was 
observed in both the cytoplasm and nucleus or in 
the cytoplasm in all types of cells examined by 
immunostaining (Fig.6). In HeLa, PC-12D, A431, 
rat-1 cells, HCC1937 and MCF-7 cells, SRB-
RGS was observed in the cytoplasm or in both the 
cytoplasm and nucleus. In COS-7, KPL-3C, MDA-
MB-231, MDA-MB-157, KPL-1 and KPL-4 cells, 
SRB-RGS was localized in both the cytoplasm and 
nucleus. 
   The SRB-RBS expressed in breast cancer cells and 
the other types of cells was quantified by real-time 
RT-PCR. Similar level of SRB-RGS was expressed 
in all the types of cells examined irrespective of the 
presence or absence of ERs and the target (MCF-7, 
MDA-MB-231, KPL-1, KPL-4, KPL-3C, BT-474, 
MDA-MB-157, HCC1937 and HeLa cells)13） or 
non-target cells (A431 cell, HUC-F2, COS-7 cells) 
for estrogen with exception of the expressed level in 
COS-7 cells (Fig.7). 
DISCUSSION
   We isolated the cDNA of a steroid receptor-
binding protein, SRB-RGS, binding to ERα as 
the first full-length RGS3 and characterized this 
protein in previous papers２，３） as well as the present 
study. A partial RGS3 had been characterized by 
Fig. 6. Immunostaining of the cells.   The cells were stained with the anti-SRB-RGS antibody (Anti) or preimmune rabbit 
immunoglobulin (IgG) and then fluorescein-5-isothiocyanate (FITC)-conjugated anti-rabbit immunoglobulin (green fluorescence). 
They were viewed on a confocal laser-scanning microscope after PI staining of the nucleus (red fluorescence).
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others11，14）. In our previous work, we showed that 
SRB-RGS was bound to the ER on DNA３） and may 
suppress the ER-mediated transcriptional abilities 
thereby. In the present paper, the effects of SRB-
RGS on the ERs-mediated transcriptional activities 
may be exerted by the PDZ domain-containing 
region and/or the RGS domain-containing region 
on SRB-RGS (Fig.2) as represented in Fig.8. That 
is, SRB-RGS may suppress the ER-mediated 
transcriptional activity via binding to ER on the 
DNA by the PDZ domain on SRB-RGS and/or via 
inhibition of phosphorylation of transcriptional 
factors containing ERs by the RGS domain on SRB-
RGS. The nuclear localization signal (NLS) was in 
the RGS domain containing at least one region of 
basic amino acids (SRB-RGS aa801-967) (Figs.3, 
4). The physiological conditions of the cells, such 
as the cell cycle and the presence or absence of 
hormones, may reflect the subcellular localization 
of SRB-RGS. Either the PDZ or the RGS domains 
on SRB-RGS induced cell death (Fig.5), suggesting 
that SRB-RGS was included in the essential survival 
signaling pathways. The overexpressed PDZ domain-
containing protein may competitively inhibit the 
essential factors for survival of HeLa cells. The 
overexpressed RGS domain may inhibit survival 
signal(s) via inhibition of G-protein. Consequently, 
either the PDZ or RGS domains on SRB-RGS 
induced cell death. The expression was observed in 
both the cytoplasm and nucleus or in the cytoplasm 
of various types of cells by confocal laser-scanning 
microscopy (Fig.6). In HeLa, PC-12D, A431, rat-1, 
HCC1937 and MCF-7 cells, the nuclear localization 
ability of SRB-RGS was reduced. In COS-7, 
KPL-3C, MDA-MB-231, MDA-MB-157, KPL-1 
and KPL-4 cells, SRB-RGS had more nuclear 
localization ability. Most of the former cell lines do 
not contain ERs. The nuclear localization ability for 
SRB-RGS in MCF-7 cells may be inhibited to some 
extent for some reason and thereby the growth of 
Fig. 7. Quantification of SRB-RGS, ERα and ERβ expressions in the cells by real time RT-PCR.  Quantification of SRB-RGS, 
ERα, ERβ and 18S rRNA expressions in the cells was performed by real-time RT-PCR.  The values of the SRB-RGS, ERα and 
ERβ gene expression were normalized by the respective value for the 18S rRNA expression. Values are the means of three or 
more independent experiments±SD. The bares of ERα of MCF-7 cells, MDA-MB-231 cell and KPL-3C cell were shorten to 
relative expression value 2000 as a matter of convenience and the real values were written beside each bar. MCF: MCF-7 cells; 
231: MDA-MB-231 cells; K-1: KPL-1 cells; K-4: KPL-4 cells; K-3C: KPL-3C cells; BT: BT474 cells; 157: MDA-MB-157 cells; 
HCC: HCC-1937 cells; A431: A431 cells; HUC: HUC-F2 cells; COS: COS-7 cells; HeLa: HeLa cells. d: hormone-dependent 
cells; i: hormone-independent cells.
54 Kawasaki Medical Journal
the cells may be enhanced. The latter are mainly the 
breast cancer cells. In COS-7 cells, SRB-RGS may 
be expressed at a sufficiently high level to move into 
the nucleus (Fig.7). 
   SRB-RGS was expressed in all types of cell 
lines examined by the quantitative real-time RT-
PCR(Fig.7). MCF-7, KPL-1 and KPL-3C breast 
cancer cells (hormone-dependent cells) expressed 
high levels of ERs, which may not be suppressed 
sufficiently the transcriptional activities by SRB-
RGS. MDA-MB-157 ,  MDA-MB-231 ,  KPL-4 
and HCC1937 (hormone-independent cells) and 
BT-474 (hormone dependent cells)15） breast cancer 
cells expressed lower levels of ERs, which could 
be suppressed sufficiently by stoichiometrically 
similar level of SRB-RGS. SRB-RGS may affect 
the growth of this type of cells. Mutations or other 
functional defects of the SRB-RGS protein could 
enhance the cell growth. A431, HUC-F2, COS-7 
and HeLa cells did not express ERs. SRB-RGS 
could have something to do with the growth of the 
cells which expressed lower level of ERs. The results 
by quantitative real-time PCR (Fig.7) are consistent 
with the observations by confocal laser-scanning 
microscopy (Fig.6). Taken together, either PDZ or 
RGS domains on SRB-RGS were necessary for 
transcriptional suppression, subcellular localization 
and induction of cell death in HeLa cells. 
   Previous studies have suggested that the transcriptional 
factors containing ERs, microRNAs and estrogens 
play important roles in the breast cancer development, 
the hormone dependency and the tamoxifen 
resistance in breast cancer16－19）. SRB-RGS may also 
be concerned with comprehensive cellular events 
through PDZ and/or RGS domains in breast cancers 
and other cells. The results provided the clues that 
helped to clarify the mechanisms of the effects of 
SRB-RGS to the transcriptional activity, subcellular 
localization, cell death and the cell growth.
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